Progestins in Prostatic Cancer
- 1 January 1983
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Testosterone: A Major Determinant of Extragenital Sexual DimorphismScience, 1981
- Treatment of Prostatic Cancer with Medroxyprogesterone-Acetate (MPA)Published by Springer Nature ,1980
- Progestogens in Prostatic CancerEuropean Urology, 1978
- Megestrol acetate for treatment of advanced carcinoma of the prostateJournal of Surgical Oncology, 1975
- Rationale and results of primary endocrine therapy in patients with prostatic cancerCancer, 1973
- Suppression of Urinary Excretion of Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH) by Medroxyprogesterone AcetateJournal of Clinical Endocrinology & Metabolism, 1969
- 6α-Methyl-17α-HYDROXYPROGESTERONE 17-ACYLATES; A NEW CLASS OF POTENT PROGESTINS1Journal of the American Chemical Society, 1958
- THE INFLUENCE OF CERTAIN STEROIDS ON THE BEHAVIOR OF HUMAN PROSTATIC CANCER*Transactions of the New York Academy of Sciences, 1950
- New horizons in the surgical management of carcinoma of the prostate glandThe American Journal of Surgery, 1949